Peter Thomas Lansbury, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Parkinson Disease | 39 | 2023 | 2877 | 2.550 |
Why?
|
| Amyloid | 26 | 2022 | 841 | 2.440 |
Why?
|
| Nerve Tissue Proteins | 30 | 2006 | 4415 | 1.940 |
Why?
|
| alpha-Synuclein | 34 | 2019 | 750 | 1.850 |
Why?
|
| Synucleins | 26 | 2005 | 108 | 1.200 |
Why?
|
| Ubiquitin Thiolesterase | 10 | 2009 | 455 | 1.130 |
Why?
|
| Amyloid beta-Peptides | 23 | 2022 | 3839 | 0.980 |
Why?
|
| Protein Folding | 11 | 2005 | 870 | 0.890 |
Why?
|
| Prions | 13 | 2003 | 180 | 0.840 |
Why?
|
| Neurodegenerative Diseases | 9 | 2017 | 1088 | 0.800 |
Why?
|
| Glucosylceramidase | 6 | 2023 | 127 | 0.780 |
Why?
|
| Ligases | 4 | 2002 | 333 | 0.710 |
Why?
|
| Cell Membrane | 6 | 2011 | 3687 | 0.620 |
Why?
|
| Superoxide Dismutase | 6 | 2010 | 594 | 0.600 |
Why?
|
| Alzheimer Disease | 31 | 2022 | 8601 | 0.600 |
Why?
|
| Scrapie | 8 | 1997 | 21 | 0.530 |
Why?
|
| Microscopy, Atomic Force | 11 | 2007 | 253 | 0.490 |
Why?
|
| Circular Dichroism | 12 | 2008 | 344 | 0.480 |
Why?
|
| Nerve Degeneration | 4 | 2003 | 748 | 0.480 |
Why?
|
| PrPSc Proteins | 8 | 2003 | 32 | 0.470 |
Why?
|
| Peptide Fragments | 14 | 2003 | 5112 | 0.470 |
Why?
|
| Plaque, Amyloid | 5 | 2022 | 760 | 0.450 |
Why?
|
| Yeasts | 2 | 2009 | 279 | 0.430 |
Why?
|
| Point Mutation | 5 | 2007 | 1595 | 0.430 |
Why?
|
| Amyotrophic Lateral Sclerosis | 6 | 2010 | 1469 | 0.420 |
Why?
|
| Neurons | 10 | 2019 | 9463 | 0.380 |
Why?
|
| Acid Ceramidase | 2 | 2020 | 21 | 0.360 |
Why?
|
| Protein Structure, Secondary | 8 | 2009 | 1229 | 0.360 |
Why?
|
| Protein Structure, Quaternary | 4 | 2007 | 429 | 0.350 |
Why?
|
| Amino Acid Sequence | 22 | 2009 | 13446 | 0.340 |
Why?
|
| Dopamine | 4 | 2008 | 1607 | 0.340 |
Why?
|
| Thiolester Hydrolases | 4 | 2002 | 90 | 0.330 |
Why?
|
| Prenylation | 1 | 2009 | 37 | 0.320 |
Why?
|
| Protein Conformation | 19 | 2008 | 3968 | 0.320 |
Why?
|
| Neurofibrillary Tangles | 3 | 2003 | 457 | 0.300 |
Why?
|
| Ubiquitin-Protein Ligases | 3 | 2002 | 1899 | 0.300 |
Why?
|
| Decision Making | 1 | 2022 | 3929 | 0.300 |
Why?
|
| Fungal Proteins | 3 | 2009 | 910 | 0.290 |
Why?
|
| Amyloidosis | 5 | 2022 | 817 | 0.290 |
Why?
|
| Mutation | 17 | 2023 | 30053 | 0.290 |
Why?
|
| Lewy Bodies | 4 | 2002 | 145 | 0.290 |
Why?
|
| Molecular Sequence Data | 21 | 2006 | 17635 | 0.280 |
Why?
|
| Intracellular Membranes | 3 | 2009 | 389 | 0.280 |
Why?
|
| Glucosylceramides | 2 | 2023 | 28 | 0.270 |
Why?
|
| Protein Precursors | 3 | 2002 | 1132 | 0.270 |
Why?
|
| Amino Acid Substitution | 8 | 2009 | 1739 | 0.260 |
Why?
|
| Saccharomyces cerevisiae | 3 | 2011 | 2688 | 0.250 |
Why?
|
| Repetitive Sequences, Amino Acid | 2 | 2003 | 92 | 0.250 |
Why?
|
| Molecular Weight | 8 | 2003 | 2186 | 0.250 |
Why?
|
| Mutagenesis | 2 | 2006 | 1232 | 0.240 |
Why?
|
| Gene Library | 2 | 2005 | 1059 | 0.230 |
Why?
|
| Congo Red | 4 | 2000 | 48 | 0.230 |
Why?
|
| Sequence Analysis, Protein | 1 | 2005 | 261 | 0.230 |
Why?
|
| Isatin | 1 | 2003 | 5 | 0.230 |
Why?
|
| Dimerization | 6 | 2006 | 891 | 0.230 |
Why?
|
| Cell Aggregation | 1 | 2004 | 239 | 0.230 |
Why?
|
| Protein Denaturation | 6 | 2006 | 242 | 0.220 |
Why?
|
| Cell Membrane Permeability | 2 | 2002 | 575 | 0.220 |
Why?
|
| Endopeptidases | 6 | 2000 | 774 | 0.220 |
Why?
|
| Recombinant Proteins | 11 | 2017 | 6534 | 0.220 |
Why?
|
| Protein Binding | 10 | 2009 | 9353 | 0.220 |
Why?
|
| Ultracentrifugation | 5 | 2003 | 183 | 0.210 |
Why?
|
| Gaucher Disease | 2 | 2020 | 110 | 0.210 |
Why?
|
| Structure-Activity Relationship | 9 | 2020 | 3076 | 0.210 |
Why?
|
| Ubiquitin | 2 | 2007 | 839 | 0.210 |
Why?
|
| Farnesyltranstransferase | 1 | 2022 | 71 | 0.210 |
Why?
|
| Mutation, Missense | 3 | 2002 | 2571 | 0.200 |
Why?
|
| Enzyme Inhibitors | 4 | 2020 | 3713 | 0.200 |
Why?
|
| Chromatography, Gel | 5 | 2008 | 646 | 0.200 |
Why?
|
| Porins | 1 | 2002 | 78 | 0.200 |
Why?
|
| Myofibrils | 1 | 2002 | 141 | 0.200 |
Why?
|
| Disulfides | 1 | 2004 | 465 | 0.200 |
Why?
|
| Oximes | 1 | 2003 | 303 | 0.200 |
Why?
|
| Oxazolone | 1 | 2020 | 61 | 0.180 |
Why?
|
| Phospholipids | 2 | 2003 | 786 | 0.180 |
Why?
|
| Sphingolipids | 1 | 2022 | 174 | 0.180 |
Why?
|
| Humans | 86 | 2023 | 761596 | 0.180 |
Why?
|
| Allelic Imbalance | 1 | 2021 | 77 | 0.180 |
Why?
|
| Cytoplasm | 2 | 2002 | 1510 | 0.180 |
Why?
|
| Models, Molecular | 12 | 2018 | 5439 | 0.180 |
Why?
|
| Kinetics | 8 | 2020 | 6374 | 0.180 |
Why?
|
| COS Cells | 3 | 2009 | 1130 | 0.170 |
Why?
|
| Permeability | 4 | 2003 | 723 | 0.170 |
Why?
|
| Protein Processing, Post-Translational | 3 | 2008 | 1974 | 0.170 |
Why?
|
| Disease Models, Animal | 6 | 2022 | 18255 | 0.170 |
Why?
|
| Rhenium | 1 | 1999 | 14 | 0.170 |
Why?
|
| Solubility | 8 | 2020 | 1091 | 0.170 |
Why?
|
| R-SNARE Proteins | 1 | 2019 | 75 | 0.170 |
Why?
|
| Animals | 41 | 2022 | 168475 | 0.170 |
Why?
|
| Lysosomes | 3 | 2019 | 924 | 0.170 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2023 | 1844 | 0.160 |
Why?
|
| Benzoxazoles | 1 | 2020 | 90 | 0.160 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 5 | 2000 | 161 | 0.160 |
Why?
|
| Saccharomyces cerevisiae Proteins | 2 | 1999 | 1841 | 0.160 |
Why?
|
| Memory Disorders | 1 | 2006 | 1199 | 0.160 |
Why?
|
| Models, Biological | 9 | 2008 | 9469 | 0.150 |
Why?
|
| Synapses | 2 | 2006 | 1769 | 0.150 |
Why?
|
| Inclusion Bodies | 1 | 2000 | 281 | 0.150 |
Why?
|
| Biopolymers | 4 | 2001 | 184 | 0.150 |
Why?
|
| Allosteric Site | 1 | 2018 | 103 | 0.150 |
Why?
|
| Guanidines | 3 | 1997 | 194 | 0.150 |
Why?
|
| Prion Diseases | 3 | 1999 | 100 | 0.150 |
Why?
|
| Microscopy, Electron | 5 | 2007 | 2561 | 0.140 |
Why?
|
| Computational Biology | 2 | 2010 | 3517 | 0.140 |
Why?
|
| Protein Structure, Tertiary | 4 | 2007 | 3792 | 0.140 |
Why?
|
| Nortriptyline | 1 | 2017 | 79 | 0.140 |
Why?
|
| Peptides | 4 | 2003 | 4358 | 0.140 |
Why?
|
| Brain | 12 | 2020 | 27121 | 0.140 |
Why?
|
| Mutagenesis, Site-Directed | 4 | 2010 | 1693 | 0.140 |
Why?
|
| Sequence Analysis, DNA | 2 | 2021 | 4740 | 0.140 |
Why?
|
| Genes, Fungal | 1 | 1997 | 439 | 0.130 |
Why?
|
| Thermodynamics | 5 | 2006 | 595 | 0.130 |
Why?
|
| Organometallic Compounds | 1 | 1999 | 647 | 0.130 |
Why?
|
| Drug Design | 1 | 2020 | 1048 | 0.130 |
Why?
|
| Threonine | 3 | 2000 | 271 | 0.120 |
Why?
|
| Half-Life | 3 | 2020 | 651 | 0.120 |
Why?
|
| Endopeptidase K | 5 | 2002 | 23 | 0.120 |
Why?
|
| Nerve Fibers | 1 | 1997 | 708 | 0.110 |
Why?
|
| PrPC Proteins | 3 | 1999 | 38 | 0.110 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2006 | 2748 | 0.110 |
Why?
|
| Periplasmic Proteins | 1 | 1992 | 25 | 0.110 |
Why?
|
| Protein Multimerization | 1 | 2018 | 983 | 0.100 |
Why?
|
| Alanine | 3 | 2000 | 609 | 0.100 |
Why?
|
| Binding Sites | 5 | 2020 | 6056 | 0.100 |
Why?
|
| Mice | 17 | 2022 | 81539 | 0.100 |
Why?
|
| Nucleic Acids | 1 | 1995 | 188 | 0.100 |
Why?
|
| Escherichia coli | 5 | 2017 | 4217 | 0.100 |
Why?
|
| Antithrombin III | 1 | 1992 | 128 | 0.100 |
Why?
|
| Double-Blind Method | 2 | 2023 | 12341 | 0.100 |
Why?
|
| Molecular Chaperones | 2 | 2008 | 754 | 0.100 |
Why?
|
| Inhibitory Concentration 50 | 2 | 2020 | 465 | 0.090 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2009 | 1321 | 0.090 |
Why?
|
| Software | 1 | 2005 | 4434 | 0.090 |
Why?
|
| Cloning, Molecular | 3 | 2003 | 4174 | 0.090 |
Why?
|
| Macromolecular Substances | 3 | 2003 | 1434 | 0.090 |
Why?
|
| Aging | 3 | 2006 | 8710 | 0.090 |
Why?
|
| Lewy Body Disease | 2 | 2006 | 252 | 0.090 |
Why?
|
| Synaptic Vesicles | 2 | 2002 | 190 | 0.090 |
Why?
|
| Neuroprotective Agents | 1 | 2017 | 957 | 0.090 |
Why?
|
| Cell Line, Tumor | 6 | 2020 | 16990 | 0.090 |
Why?
|
| Adsorption | 2 | 2001 | 197 | 0.090 |
Why?
|
| Micelles | 2 | 2008 | 192 | 0.090 |
Why?
|
| X-Ray Diffraction | 3 | 2000 | 421 | 0.090 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 1992 | 406 | 0.090 |
Why?
|
| Molecular Structure | 4 | 2020 | 1880 | 0.080 |
Why?
|
| Apolipoproteins E | 1 | 1995 | 1443 | 0.080 |
Why?
|
| Benzothiazoles | 2 | 2000 | 247 | 0.080 |
Why?
|
| Spectrophotometry, Infrared | 3 | 1993 | 117 | 0.080 |
Why?
|
| Spectrometry, Fluorescence | 2 | 2001 | 685 | 0.080 |
Why?
|
| Peptide Termination Factors | 2 | 1999 | 56 | 0.080 |
Why?
|
| Solutions | 2 | 2002 | 412 | 0.080 |
Why?
|
| Age of Onset | 3 | 2000 | 3306 | 0.080 |
Why?
|
| Autophagy | 2 | 2008 | 1327 | 0.080 |
Why?
|
| Mutant Proteins | 1 | 2010 | 491 | 0.080 |
Why?
|
| Phosphoproteins | 3 | 2002 | 2448 | 0.070 |
Why?
|
| Chemistry, Physical | 2 | 2000 | 154 | 0.070 |
Why?
|
| Brain Chemistry | 3 | 2002 | 960 | 0.070 |
Why?
|
| Lipoproteins | 1 | 1992 | 881 | 0.070 |
Why?
|
| Chemical Phenomena | 2 | 2000 | 507 | 0.070 |
Why?
|
| Models, Neurological | 2 | 2007 | 1769 | 0.070 |
Why?
|
| Cysteine Endopeptidases | 2 | 2007 | 551 | 0.070 |
Why?
|
| Transformation, Genetic | 1 | 2006 | 192 | 0.070 |
Why?
|
| Methionine | 1 | 2009 | 572 | 0.070 |
Why?
|
| Cricetinae | 7 | 1998 | 2423 | 0.070 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2006 | 460 | 0.060 |
Why?
|
| Electroporation | 1 | 2006 | 255 | 0.060 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2006 | 3733 | 0.060 |
Why?
|
| Mesocricetus | 4 | 1997 | 252 | 0.060 |
Why?
|
| Heparin | 1 | 1992 | 1634 | 0.060 |
Why?
|
| Endoplasmic Reticulum | 2 | 2009 | 1134 | 0.060 |
Why?
|
| Small Molecule Libraries | 1 | 2010 | 733 | 0.060 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2007 | 509 | 0.060 |
Why?
|
| Prealbumin | 2 | 2003 | 222 | 0.060 |
Why?
|
| Neurofibrils | 1 | 2004 | 75 | 0.060 |
Why?
|
| Cysteine | 1 | 2009 | 891 | 0.060 |
Why?
|
| Cell-Free System | 4 | 1999 | 340 | 0.060 |
Why?
|
| Serine | 1 | 2008 | 831 | 0.060 |
Why?
|
| Mice, Transgenic | 3 | 2022 | 9542 | 0.060 |
Why?
|
| Enzyme Stability | 1 | 2004 | 219 | 0.060 |
Why?
|
| Multiprotein Complexes | 2 | 2007 | 1120 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 2 | 2021 | 6075 | 0.060 |
Why?
|
| gamma-Synuclein | 1 | 2003 | 9 | 0.050 |
Why?
|
| Lactosylceramides | 1 | 2023 | 15 | 0.050 |
Why?
|
| Propanols | 1 | 2003 | 9 | 0.050 |
Why?
|
| beta-Synuclein | 1 | 2003 | 14 | 0.050 |
Why?
|
| Neuroblastoma | 1 | 2011 | 1250 | 0.050 |
Why?
|
| Hydrogen | 1 | 2003 | 172 | 0.050 |
Why?
|
| Cerebral Cortex | 1 | 1999 | 5779 | 0.050 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2010 | 1334 | 0.050 |
Why?
|
| Guanidine | 3 | 1997 | 35 | 0.050 |
Why?
|
| Magnetic Resonance Spectroscopy | 4 | 2008 | 3769 | 0.050 |
Why?
|
| Islet Amyloid Polypeptide | 1 | 2002 | 42 | 0.050 |
Why?
|
| Crystallization | 2 | 1995 | 534 | 0.050 |
Why?
|
| Thiazoles | 2 | 2000 | 1517 | 0.050 |
Why?
|
| Rats | 6 | 2008 | 23741 | 0.050 |
Why?
|
| Administration, Oral | 2 | 2020 | 4021 | 0.050 |
Why?
|
| Oligonucleotides | 1 | 2005 | 582 | 0.050 |
Why?
|
| Huntington Disease | 2 | 2000 | 1144 | 0.050 |
Why?
|
| Genetic Variation | 4 | 2007 | 6567 | 0.050 |
Why?
|
| Quinones | 1 | 2001 | 78 | 0.050 |
Why?
|
| Amyloidogenic Proteins | 1 | 2022 | 151 | 0.050 |
Why?
|
| Phosphatidylglycerols | 1 | 2001 | 34 | 0.050 |
Why?
|
| Phosphatidic Acids | 1 | 2001 | 49 | 0.050 |
Why?
|
| Green Fluorescent Proteins | 1 | 2006 | 2065 | 0.050 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2008 | 506 | 0.050 |
Why?
|
| Cell Death | 1 | 2006 | 1679 | 0.050 |
Why?
|
| Levodopa | 1 | 2001 | 221 | 0.050 |
Why?
|
| Microsomes | 1 | 2020 | 251 | 0.050 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2022 | 311 | 0.050 |
Why?
|
| Catecholamines | 1 | 2001 | 386 | 0.050 |
Why?
|
| Cytotoxins | 1 | 2001 | 153 | 0.040 |
Why?
|
| Psychosine | 1 | 2020 | 8 | 0.040 |
Why?
|
| Antineoplastic Agents | 1 | 2003 | 13642 | 0.040 |
Why?
|
| Amyloid Neuropathies | 1 | 2000 | 15 | 0.040 |
Why?
|
| Coloring Agents | 2 | 2000 | 562 | 0.040 |
Why?
|
| Leukodystrophy, Globoid Cell | 1 | 2020 | 38 | 0.040 |
Why?
|
| Transfection | 2 | 2011 | 5774 | 0.040 |
Why?
|
| Postmortem Changes | 1 | 2000 | 119 | 0.040 |
Why?
|
| Microscopy, Polarization | 1 | 2000 | 89 | 0.040 |
Why?
|
| beta-Galactosidase | 1 | 2001 | 574 | 0.040 |
Why?
|
| Phosphatidylcholines | 1 | 2001 | 405 | 0.040 |
Why?
|
| Peptide Chain Elongation, Translational | 1 | 1999 | 31 | 0.040 |
Why?
|
| Organotechnetium Compounds | 1 | 1999 | 129 | 0.040 |
Why?
|
| Amyloid beta-Protein Precursor | 2 | 2022 | 1111 | 0.040 |
Why?
|
| Bacterial Proteins | 1 | 1992 | 3847 | 0.040 |
Why?
|
| Lung Neoplasms | 1 | 2003 | 13381 | 0.040 |
Why?
|
| Hydrolysis | 1 | 2000 | 664 | 0.040 |
Why?
|
| Isoenzymes | 1 | 2003 | 1687 | 0.040 |
Why?
|
| Crystallography, X-Ray | 2 | 2018 | 1990 | 0.040 |
Why?
|
| Glutathione Peroxidase | 1 | 1999 | 258 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2002 | 12149 | 0.040 |
Why?
|
| Particle Size | 1 | 2002 | 1648 | 0.040 |
Why?
|
| Proline | 1 | 2000 | 457 | 0.040 |
Why?
|
| Glycerol | 1 | 1999 | 274 | 0.040 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2022 | 620 | 0.040 |
Why?
|
| Caveolins | 1 | 1998 | 102 | 0.040 |
Why?
|
| Gene Dosage | 1 | 2002 | 1218 | 0.040 |
Why?
|
| Protein Transport | 2 | 2019 | 1967 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2003 | 1699 | 0.040 |
Why?
|
| Time Factors | 5 | 2002 | 39969 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2000 | 2496 | 0.040 |
Why?
|
| Mass Spectrometry | 2 | 2018 | 2192 | 0.040 |
Why?
|
| Encephalopathy, Bovine Spongiform | 1 | 1997 | 6 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2021 | 10766 | 0.040 |
Why?
|
| Molecular Conformation | 2 | 2010 | 544 | 0.040 |
Why?
|
| Cell Compartmentation | 1 | 1998 | 384 | 0.040 |
Why?
|
| Protein Unfolding | 1 | 2017 | 56 | 0.040 |
Why?
|
| Fluorescence | 1 | 2000 | 756 | 0.040 |
Why?
|
| Sodium Chloride | 1 | 1999 | 587 | 0.040 |
Why?
|
| Slow Virus Diseases | 1 | 1996 | 4 | 0.030 |
Why?
|
| Light | 1 | 2003 | 1353 | 0.030 |
Why?
|
| Mutagenesis, Insertional | 1 | 1999 | 656 | 0.030 |
Why?
|
| Substantia Nigra | 1 | 1998 | 350 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2021 | 1638 | 0.030 |
Why?
|
| Zoonoses | 1 | 1997 | 179 | 0.030 |
Why?
|
| Blotting, Western | 2 | 2011 | 5035 | 0.030 |
Why?
|
| Rabbits | 1 | 2002 | 4772 | 0.030 |
Why?
|
| Sulfur Radioisotopes | 1 | 1995 | 113 | 0.030 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2001 | 604 | 0.030 |
Why?
|
| Lipids | 1 | 2007 | 3341 | 0.030 |
Why?
|
| Antigens, CD | 2 | 2023 | 4001 | 0.030 |
Why?
|
| Cell Division | 1 | 2003 | 4465 | 0.030 |
Why?
|
| Ultrafiltration | 1 | 1995 | 49 | 0.030 |
Why?
|
| Netherlands | 1 | 2020 | 2221 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2001 | 2231 | 0.030 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 2017 | 432 | 0.030 |
Why?
|
| Hydrostatic Pressure | 2 | 2007 | 98 | 0.030 |
Why?
|
| Staining and Labeling | 1 | 1999 | 1085 | 0.030 |
Why?
|
| Exons | 1 | 2021 | 2391 | 0.030 |
Why?
|
| Apolipoprotein E3 | 1 | 1995 | 107 | 0.030 |
Why?
|
| Molecular Probes | 1 | 1996 | 309 | 0.030 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 1999 | 1068 | 0.030 |
Why?
|
| Genome | 1 | 2002 | 1740 | 0.030 |
Why?
|
| Substrate Specificity | 2 | 2010 | 1791 | 0.030 |
Why?
|
| Axons | 1 | 2022 | 1674 | 0.030 |
Why?
|
| Antioxidants | 1 | 2001 | 1668 | 0.030 |
Why?
|
| Membrane Proteins | 2 | 2009 | 7859 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1995 | 1741 | 0.030 |
Why?
|
| Random Allocation | 1 | 2017 | 2395 | 0.030 |
Why?
|
| Models, Chemical | 1 | 1995 | 611 | 0.030 |
Why?
|
| Temperature | 1 | 1999 | 2226 | 0.030 |
Why?
|
| Rats, Wistar | 2 | 2008 | 1848 | 0.030 |
Why?
|
| Animals, Genetically Modified | 1 | 2017 | 1561 | 0.030 |
Why?
|
| Models, Genetic | 1 | 2002 | 3442 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 2019 | 1403 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 2002 | 4243 | 0.020 |
Why?
|
| Fourier Analysis | 1 | 1992 | 441 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2020 | 22174 | 0.020 |
Why?
|
| Cells, Cultured | 3 | 2019 | 18966 | 0.020 |
Why?
|
| Binding, Competitive | 1 | 1992 | 1141 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2001 | 3113 | 0.020 |
Why?
|
| Apolipoprotein E4 | 1 | 1995 | 709 | 0.020 |
Why?
|
| Buffers | 1 | 2010 | 146 | 0.020 |
Why?
|
| Absorption | 1 | 2010 | 242 | 0.020 |
Why?
|
| Drosophila | 1 | 2017 | 1495 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2002 | 17904 | 0.020 |
Why?
|
| Radiopharmaceuticals | 1 | 1999 | 2650 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2017 | 8181 | 0.020 |
Why?
|
| Genome, Human | 1 | 2002 | 4425 | 0.020 |
Why?
|
| Mitochondria | 1 | 2002 | 3624 | 0.020 |
Why?
|
| Water | 2 | 2007 | 1411 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 1997 | 2910 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2018 | 4281 | 0.020 |
Why?
|
| Uracil | 1 | 2010 | 207 | 0.020 |
Why?
|
| Tretinoin | 1 | 2011 | 519 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 2011 | 1991 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2018 | 4142 | 0.020 |
Why?
|
| Species Specificity | 3 | 1997 | 2414 | 0.020 |
Why?
|
| Polymers | 1 | 1994 | 1616 | 0.020 |
Why?
|
| Phosphorylation | 2 | 2008 | 8321 | 0.020 |
Why?
|
| Drug Stability | 1 | 2007 | 291 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2004 | 22176 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2000 | 11076 | 0.020 |
Why?
|
| Nervous System Diseases | 1 | 1996 | 1667 | 0.020 |
Why?
|
| Virus Replication | 1 | 1993 | 2435 | 0.020 |
Why?
|
| Proteins | 1 | 2000 | 6032 | 0.020 |
Why?
|
| Dementia | 1 | 2000 | 2689 | 0.020 |
Why?
|
| Catalysis | 1 | 2006 | 774 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 1999 | 5799 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2000 | 14417 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 2008 | 1749 | 0.010 |
Why?
|
| Algorithms | 1 | 2005 | 14033 | 0.010 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 2004 | 78 | 0.010 |
Why?
|
| PC12 Cells | 1 | 2004 | 317 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2011 | 2645 | 0.010 |
Why?
|
| Deuterium Exchange Measurement | 1 | 2003 | 31 | 0.010 |
Why?
|
| Liposomes | 1 | 2008 | 783 | 0.010 |
Why?
|
| Male | 6 | 2020 | 360846 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2011 | 2932 | 0.010 |
Why?
|
| Ligands | 1 | 2010 | 3272 | 0.010 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2003 | 266 | 0.010 |
Why?
|
| Amino Acid Motifs | 1 | 2004 | 931 | 0.010 |
Why?
|
| Swine | 1 | 1992 | 5915 | 0.010 |
Why?
|
| Phenotype | 1 | 1999 | 16592 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2010 | 4111 | 0.010 |
Why?
|
| Cell Survival | 1 | 2011 | 5791 | 0.010 |
Why?
|
| Isoelectric Point | 1 | 2000 | 76 | 0.010 |
Why?
|
| Sodium Hydroxide | 1 | 2000 | 37 | 0.010 |
Why?
|
| Freeze Drying | 1 | 2000 | 101 | 0.010 |
Why?
|
| Filtration | 1 | 2000 | 228 | 0.010 |
Why?
|
| Solvents | 1 | 2000 | 295 | 0.010 |
Why?
|
| Methods | 1 | 1999 | 1067 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 2 | 1997 | 6131 | 0.010 |
Why?
|
| Detergents | 1 | 1998 | 236 | 0.010 |
Why?
|
| Glycolipids | 1 | 1998 | 206 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 1998 | 532 | 0.010 |
Why?
|
| PrP 27-30 Protein | 1 | 1996 | 1 | 0.010 |
Why?
|
| Creutzfeldt-Jakob Syndrome | 1 | 1997 | 93 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2000 | 1541 | 0.010 |
Why?
|
| United States | 1 | 2005 | 72340 | 0.010 |
Why?
|
| Golgi Apparatus | 1 | 1998 | 405 | 0.010 |
Why?
|
| Caveolin 1 | 1 | 1998 | 256 | 0.010 |
Why?
|
| Coculture Techniques | 1 | 2000 | 1341 | 0.010 |
Why?
|
| Cetylpyridinium | 1 | 1995 | 6 | 0.010 |
Why?
|
| CHO Cells | 1 | 1998 | 1387 | 0.010 |
Why?
|
| Tunicamycin | 1 | 1995 | 108 | 0.010 |
Why?
|
| Models, Structural | 1 | 1995 | 340 | 0.010 |
Why?
|
| Culture Techniques | 1 | 1995 | 531 | 0.010 |
Why?
|
| Sheep | 1 | 1997 | 1440 | 0.010 |
Why?
|
| Neuroglia | 1 | 2000 | 956 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2011 | 11530 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 1995 | 1762 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 1999 | 1668 | 0.010 |
Why?
|
| Glycosylation | 1 | 1995 | 1097 | 0.010 |
Why?
|
| Child | 1 | 2020 | 80158 | 0.010 |
Why?
|
| Cattle | 1 | 1997 | 3849 | 0.010 |
Why?
|
| Female | 2 | 2020 | 392705 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 1997 | 1787 | 0.010 |
Why?
|
| Serine Endopeptidases | 1 | 1995 | 1023 | 0.010 |
Why?
|
| Cholesterol | 1 | 1998 | 2905 | 0.010 |
Why?
|
| Drug Resistance | 1 | 1995 | 1596 | 0.010 |
Why?
|
| Aged | 1 | 2021 | 169310 | 0.000 |
Why?
|
| Middle Aged | 1 | 2021 | 220921 | 0.000 |
Why?
|